-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Alto Neuroscience, Raises Price Target to $22

Benzinga·11/13/2025 12:35:10
Listen to the news
Baird analyst Brian Skorney maintains Alto Neuroscience (NYSE:ANRO) with a Outperform and raises the price target from $16 to $22.